Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

CNS-selective effects of synthetic, nonfeminizing estrogens

July 7, 1998

Ganaxolone study results presented at AASH meeting

July 7, 1998

Phase I results reported for new AIDS vaccine candidate

July 6, 1998

AIDS vaccine combination shows excellent prophylactic efficacy in clinical trial

July 6, 1998

Chemokine antagonist inhibits HIV-1 infectivity at nontoxic concentrations

July 6, 1998

IL-2 shown effective in patients with advanced-stage HIV disease

July 6, 1998

CHEESE study points to differing immune responses to two different protease inhibitors

July 6, 1998

Further data support development of TAS-301 for restenosis

July 3, 1998

BO-653: an antioxidant with potential in restenosis

July 3, 1998

Novel ACAT inhibitor from Nihon Nohyaku for hyperlipidemia and atherosclerosis

July 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...